John Johnson Xeris Biopharma Holdings, Inc. (XERS) insider trading activity
John Johnson is Director of Xeris Biopharma Holdings, Inc.. Currently has a direct ownership of 890,983 shares of XERS, which is worth approximately $2.75 Million. The most recent transaction as insider was on Jun 05, 2024, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
891K
0%
3M change
66.29%
12M change
Total Value Held
$2.75 Million
JOHN JOHNSON Transaction History
Also insider at
JJ
John Johnson
Director
Trevose, PA